Skip to main content

News

  • Press Releases
  • Presentations & Publications
  • In The News
August 2, 2022
IDRx Launches with $122 Million Series A Financing to Treat Cancer with Purpose-Built Precision Combination Therapies
Read More
Intelligently Designed Precision Combinations to Transform Cancer Care
info@idrx.com
careers@idrx.com
media@idrx.com
  • Our Approach
  • Who We Are
  • Press Releases
© 2023 IDRx Inc. Privacy Policy. Terms of Use.